RESUMO
Chronic obesity causes various diseases, leading to an urgent need for its treatment and prevention. Using monosodium-glutamate-induced obesity mice, the present study investigated the synergistic obesity-reducing effects of tea catechins and the antioxidant ß-cryptoxanthin present in mandarin oranges. The results show that the obese mice that ingested both tea catechin and ß-cryptoxanthin for 4 weeks had a significantly decreased body weight, with no difference in body weight compared with control mice. Moreover, the blood biochemical test results were normal, and the body fat percentage was significantly decreased according to the histopathological analysis. Additionally, the abundance of M1 macrophages, which release pro-inflammatories, was significantly reduced in adipose tissue. Indeed, a significant decrease was detected in M1-macrophage-secreted tumor necrosis factor-alpha levels. Meanwhile, M2 macrophage levels were recovered, and adiponectin, which is released from adipocytes and involved in suppressing metabolic syndrome, was increased. Collectively, these results suggest that the combination of tea catechins and antioxidant foods can alleviate chronic obesity, indicating that a combination of various ingredients in foods might contribute to reducing chronic obesity.
Assuntos
Catequina , Chá , Animais , Camundongos , Chá/metabolismo , beta-Criptoxantina/metabolismo , beta-Criptoxantina/farmacologia , beta-Criptoxantina/uso terapêutico , Camundongos Obesos , Catequina/uso terapêutico , Antioxidantes/metabolismo , Obesidade/tratamento farmacológico , Obesidade/etiologia , Peso Corporal , Tecido Adiposo/metabolismo , Ingestão de Alimentos , Anti-Inflamatórios/uso terapêuticoRESUMO
The efficacy of ß-cryptoxanthin (BCX), a high-protein diet (HPD), or both in reducing oxidative stress and inflammation in nonalcoholic fatty liver disease (NAFLD) has never been examined within a randomized controlled trial (RCT). Thus, we aimed to assess the efficacy of an energy-restricted HPD supplemented with BCX in alleviating these conditions in NAFLD in an RCT design. We hypothesized that this combination may improve oxidative stress and inflammation in NAFLD as compared to a standard energy-restricted diet. Ninety-two ultrasonographically confirmed overweight/obese adult NAFLD patients attending an outpatient clinic in Ahvaz, Iran, were recruited for this 12-week, single-center, parallel-group, double-blind RCT from 2017 to 2018. Subjects were randomized into 4 equal groups (nâ¯=â¯23): HPD-BCX (energy-restricted HPDâ¯+â¯BCX), HPD (energy-restricted HPDâ¯+â¯placebo), BCX (standard energy-restricted diet + BCX), and control (standard energy-restricted diet + placebo). Serum levels of oxidative stress- and inflammation-related markers, as primary outcome measures, were determined at baseline and at the study end point. The 1-way analysis of covariance models in the intention-to-treat population (Nâ¯=â¯92) showed that the HPD-BCX group achieved greater 12-week reductions in malondialdehyde, high-sensitivity C-reactive protein, interleukin-6, and total cytokeratin-18 (CK18-M65) but higher increases in total antioxidant capacity and adiponectin compared to the control group (mean differences for malondialdehyde, high-sensitivity C-reactive protein, interleukin-6, total cytokeratin-18, total antioxidant capacity, and adiponectin were -1.9â¯nmol/mL, -1.0â¯mg/L, -2.0â¯ng/L, -270.9â¯ng/L, 2.5â¯U/mL, and 1.9â¯mg/L, respectively; all Pâ¯<â¯.001). These results show that an energy-restricted HPD supplemented with BCX more efficaciously alleviates oxidative stress and inflammation in NAFLD as compared to a standard energy-restricted diet.
Assuntos
beta-Criptoxantina/uso terapêutico , Restrição Calórica/métodos , Dieta Rica em Proteínas/métodos , Inflamação/terapia , Hepatopatia Gordurosa não Alcoólica/terapia , Estresse Oxidativo/efeitos dos fármacos , Adulto , beta-Criptoxantina/sangue , Biomarcadores/sangue , Terapia Combinada/métodos , Suplementos Nutricionais , Método Duplo-Cego , Feminino , Humanos , Inflamação/dietoterapia , Inflamação/tratamento farmacológico , Irã (Geográfico) , Masculino , Hepatopatia Gordurosa não Alcoólica/sangue , Hepatopatia Gordurosa não Alcoólica/dietoterapia , Hepatopatia Gordurosa não Alcoólica/tratamento farmacológico , Provitaminas/sangue , Provitaminas/uso terapêutico , Resultado do TratamentoRESUMO
ß-Cryptoxanthin, which is primarily obtained from citrus fruits such as Satsuma mandarins, is a major carotenoid routinely found in human serum. Recently, we demonstrated that daily oral intake of ß-cryptoxanthin prevented ovariectomy-induced bone loss and ameliorated neuropathic pain in mice. Although ß-cryptoxanthin exerts preventive effects on various lifestyle-related diseases, there have been no studies on the effect of ß-cryptoxanthin on the development of osteoarthritis, the most common degenerative joint disease, which frequently leads to loss of ability and stiffness in the elderly. Here we showed that daily oral administration of ß-cryptoxanthin significantly prevented the development of osteoarthritis developed by surgically inducing knee joint instability in mice in vivo. Furthermore, in vitro experiments revealed that ß-cryptoxanthin markedly inhibited the expression of inflammatory cytokines and enzymes critical for the degradation of the extracellular matrix in primary chondrocytes. Our results suggest that oral supplementation of ß-cryptoxanthin would be beneficial for the maintenance of joint health and as prophylaxis against osteoarthritis.
Assuntos
beta-Criptoxantina/uso terapêutico , Osteoartrite/prevenção & controle , Animais , beta-Criptoxantina/administração & dosagem , Condrócitos/metabolismo , Citocinas/metabolismo , Mediadores da Inflamação/metabolismo , Camundongos , Osteoartrite/tratamento farmacológicoRESUMO
ß-cryptoxanthin, a xanthophyll carotenoid, exerts preventive effects on various lifestyle-related diseases. Here, we found that daily oral administration of ß-cryptoxanthin significantly ameliorated the development of tactile allodynia following spinal nerve injury but was ineffective in mechanical allodynia in an inflammatory pain model in mice. Our results suggest that ß-cryptoxanthin supplementation would be beneficial for the prophylaxis of neuropathic pain.